Published in Neuroimage on October 01, 2005
Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage (2012) 5.11
The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol (2010) 4.59
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Brain (2010) 4.39
Epidemiology of Alzheimer disease. Nat Rev Neurol (2011) 4.13
3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain (2007) 3.53
Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects. Neuroimage (2008) 3.40
Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Curr Alzheimer Res (2009) 3.31
MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology (2007) 3.24
The cortical signature of prodromal AD: regional thinning predicts mild AD dementia. Neurology (2008) 2.91
Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Radiology (2009) 2.90
The role of biomarkers in clinical trials for Alzheimer disease. Alzheimer Dis Assoc Disord (2006) 2.86
Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med (2010) 2.77
Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology (2009) 2.70
MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study. Neurology (2008) 2.69
Longitudinal change of biomarkers in cognitive decline. Arch Neurol (2011) 2.51
The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation. J Neurosci (2006) 2.34
Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.30
Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Hum Brain Mapp (2009) 2.28
Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.25
Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease. J Neurosci (2008) 2.15
Statistical analysis of longitudinal neuroimage data with Linear Mixed Effects models. Neuroimage (2012) 2.11
Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. Neurobiol Aging (2010) 2.05
Multidimensional classification of hippocampal shape features discriminates Alzheimer's disease and mild cognitive impairment from normal aging. Neuroimage (2009) 1.95
Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol (2014) 1.86
Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials. Neuroimage (2012) 1.76
Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease. Neuroimage (2008) 1.74
Abnormal cortical networks in mild cognitive impairment and Alzheimer's disease. PLoS Comput Biol (2010) 1.72
Mapping Alzheimer's disease progression in 1309 MRI scans: power estimates for different inter-scan intervals. Neuroimage (2010) 1.69
Large-scale functional brain network abnormalities in Alzheimer's disease: insights from functional neuroimaging. Behav Neurol (2009) 1.58
Discriminant analysis of longitudinal cortical thickness changes in Alzheimer's disease using dynamic and network features. Neurobiol Aging (2011) 1.55
PET/MRI for neurologic applications. J Nucl Med (2012) 1.55
Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease. Neuroimage (2009) 1.55
Unbiased comparison of sample size estimates from longitudinal structural measures in ADNI. Hum Brain Mapp (2011) 1.53
Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease. Brain (2009) 1.50
Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease. Brain (2010) 1.44
CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects. Cereb Cortex (2011) 1.38
Biomarkers of Alzheimer's disease. Neurobiol Dis (2008) 1.37
Cerebral ventricular changes associated with transitions between normal cognitive function, mild cognitive impairment, and dementia. Alzheimer Dis Assoc Disord (2007) 1.35
Hippocampal activation for autobiographical memories over the entire lifetime in healthy aged subjects: an fMRI study. Cereb Cortex (2007) 1.33
Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration. Neurology (2014) 1.31
Voxel-based assessment of gray and white matter volumes in Alzheimer's disease. Neurosci Lett (2009) 1.27
Mapping progressive brain structural changes in early Alzheimer's disease and mild cognitive impairment. Neuropsychologia (2007) 1.26
MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD. Neurology (2008) 1.24
Brain mapping as a tool to study neurodegeneration. Neurotherapeutics (2007) 1.24
Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease. Radiology (2010) 1.22
Strategies for molecular imaging dementia and neurodegenerative diseases. Neuropsychiatr Dis Treat (2008) 1.21
Association of hearing impairment with brain volume changes in older adults. Neuroimage (2014) 1.21
Clinical-neuroimaging characteristics of dysexecutive mild cognitive impairment. Ann Neurol (2009) 1.21
Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review. J Am Geriatr Soc (2008) 1.20
Hearing loss and dementia - who is listening? Aging Ment Health (2014) 1.17
aBEAT: a toolbox for consistent analysis of longitudinal adult brain MRI. PLoS One (2013) 1.13
Principal component analysis of FDG PET in amnestic MCI. Eur J Nucl Med Mol Imaging (2008) 1.13
Relations of brain volumes with cognitive function in males 45 years and older with past lead exposure. Neuroimage (2007) 1.12
Biomarkers in translational research of Alzheimer's disease. Neuropharmacology (2010) 1.11
Spatiotemporal linear mixed effects modeling for the mass-univariate analysis of longitudinal neuroimage data. Neuroimage (2013) 1.11
In vivo mapping of incremental cortical atrophy from incipient to overt Alzheimer's disease. J Neurol (2009) 1.10
Age effects on hippocampal structural changes in old men: the HAAS. Neuroimage (2007) 1.09
Novel MRI techniques in the assessment of dementia. Eur J Nucl Med Mol Imaging (2008) 1.07
The effects of aging and Alzheimer's disease on cerebral cortical anatomy: specificity and differential relationships with cognition. Neuroimage (2013) 1.05
Sex differences in grey matter atrophy patterns among AD and aMCI patients: results from ADNI. Neuroimage (2011) 1.04
Ushering in the study and treatment of preclinical Alzheimer disease. Nat Rev Neurol (2013) 1.03
An approach to identify, from DCE MRI, significant subvolumes of tumors related to outcomes in advanced head-and-neck cancer. Med Phys (2012) 1.02
Exposure to herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia. Schizophr Bull (2012) 0.98
Alliance for aging research AD biomarkers work group: structural MRI. Neurobiol Aging (2011) 0.98
Brain imaging in the study of Alzheimer's disease. Neuroimage (2011) 0.97
Evidence of neurodegeneration in brains of older adults who do not yet fulfill MCI criteria. Neurobiol Aging (2008) 0.97
Structural MRI discriminates individuals with Mild Cognitive Impairment from age-matched controls: a combined neuropsychological and voxel based morphometry study. Alzheimers Dement (2006) 0.96
Global gray matter changes in posterior cortical atrophy: a serial imaging study. Alzheimers Dement (2012) 0.95
Progressive gray matter loss and changes in cognitive functioning associated with exposure to herpes simplex virus 1 in schizophrenia: a longitudinal study. Am J Psychiatry (2011) 0.94
Structural brain changes in normal individuals with a maternal history of Alzheimer's. Neurobiol Aging (2011) 0.94
The efficacy of a voxel-based morphometry on the analysis of imaging in schizophrenia, temporal lobe epilepsy, and Alzheimer's disease/mild cognitive impairment: a review. Neuroradiology (2010) 0.93
Diagnosis and biomarkers of predementia in Alzheimer's disease. BMC Med (2010) 0.93
Staging Alzheimer's disease progression with multimodality neuroimaging. Prog Neurobiol (2011) 0.92
Basal forebrain atrophy is a presymptomatic marker for Alzheimer's disease. Alzheimers Dement (2008) 0.92
Early structural changes in individuals at risk of familial Alzheimer's disease: a volumetry and magnetization transfer MR imaging study. J Neurol (2009) 0.92
Altered default-mode network activation in mild cognitive impairment compared with healthy aging. Neuroradiology (2012) 0.92
Detection of visuoperceptual deficits in preclinical and mild Alzheimer's disease. J Clin Exp Neuropsychol (2009) 0.91
Mild cognitive impairment in adult: A neuropsychological review. Ann Indian Acad Neurol (2013) 0.90
Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease. J Neurol (2009) 0.89
Gray matter concentration and effective connectivity changes in Alzheimer's disease: a longitudinal structural MRI study. Neuroradiology (2010) 0.89
Domain Transfer Learning for MCI Conversion Prediction. IEEE Trans Biomed Eng (2015) 0.89
Voxel-based analysis of 11C-PIB scans for diagnosing Alzheimer's disease. J Nucl Med (2008) 0.88
Cortical and hippocampal atrophy in patients with autosomal dominant familial Alzheimer's disease. Dement Geriatr Cogn Disord (2011) 0.88
Demyelination in mild cognitive impairment suggests progression path to Alzheimer's disease. PLoS One (2013) 0.88
Mediterranean Diet and Magnetic Resonance Imaging-Assessed Brain Atrophy in Cognitively Normal Individuals at Risk for Alzheimer's Disease. J Prev Alzheimers Dis (2014) 0.88
Assessing age-related gray matter decline with voxel-based morphometry depends significantly on segmentation and normalization procedures. Front Aging Neurosci (2014) 0.87
Biological markers for early detection and pharmacological treatment of Alzheimer's disease. Dialogues Clin Neurosci (2009) 0.86
Baseline predictors of clinical progression among patients with dysexecutive mild cognitive impairment. Dement Geriatr Cogn Disord (2010) 0.86
Dynamic Bayesian network modeling for longitudinal brain morphometry. Neuroimage (2011) 0.86
Looking beyond the hippocampus: old and new neurological targets for understanding memory disorders. Proc Biol Sci (2014) 0.86
Dynamics of endogenous Hsp70 synthesis in the brain of olfactory bulbectomized mice. Cell Stress Chaperones (2012) 0.85
Structural MRI in frontotemporal dementia: comparisons between hippocampal volumetry, tensor-based morphometry and voxel-based morphometry. PLoS One (2012) 0.84
Magnetic resonance imaging of Alzheimer's disease. Eur Radiol (2006) 0.84
Selective changes of resting-state brain oscillations in aMCI: an fMRI study using ALFF. Biomed Res Int (2014) 0.84
Correlation between volume and morphological changes in the hippocampal formation in Alzheimer's disease: rounding of the outline of the hippocampal body on coronal MR images. Neuroradiology (2012) 0.83
Morphological and glucose metabolism abnormalities in alcoholic Korsakoff's syndrome: group comparisons and individual analyses. PLoS One (2009) 0.83
Detecting Anatomical Landmarks for Fast Alzheimer's Disease Diagnosis. IEEE Trans Med Imaging (2016) 0.82
Dementia and the default mode. Curr Alzheimer Res (2011) 0.82
Temporal and spatial evolution of grey matter atrophy in primary progressive multiple sclerosis. Neuroimage (2013) 0.82
Altered Functional Connectivity of Fusiform Gyrus in Subjects with Amnestic Mild Cognitive Impairment: A Resting-State fMRI Study. Front Hum Neurosci (2015) 0.82
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage (2002) 49.90
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage (2002) 3.88
In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage (2001) 3.87
Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology (2003) 3.60
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst (1995) 3.25
Regional differences in semen quality in Europe. Hum Reprod (2001) 3.19
Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol (1996) 2.54
Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease. Brain (2007) 2.17
MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology (2004) 2.07
PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcome. Lancet (1993) 1.92
The functional neuroanatomy of episodic memory: the role of the frontal lobes, the hippocampal formation, and other areas. Neuroimage (1998) 1.92
Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxel-based data analysis. Stroke (1996) 1.78
The structural components of music perception. A functional anatomical study. Brain (1997) 1.66
Time to pregnancy and semen parameters: a cross-sectional study among fertile couples from four European cities. Hum Reprod (2002) 1.55
The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization. Brain (1998) 1.49
Utility of an ultrafast magnetic resonance imaging protocol in recent and semi-recent strokes. J Neurol Neurosurg Psychiatry (2005) 1.43
Episodic memory in transient global amnesia: encoding, storage, or retrieval deficit? J Neurol Neurosurg Psychiatry (1999) 1.42
Nitrous oxide anesthesia-associated myelopathy. Arch Neurol (2000) 1.40
Plasma superoxide dismutase and glutathione peroxidase activity in sporadic amyotrophic lateral sclerosis. J Neurol Sci (1997) 1.39
Voxel-based mapping of brain hypometabolism in permanent amnesia with PET. Neuroimage (2001) 1.39
Magnetic resonance imaging in temporal lobe epilepsy: pathological correlations. Ann Neurol (1987) 1.35
Does healthy aging affect the hemispheric activation balance during paced index-to-thumb opposition task? An fMRI study. Neuroimage (2006) 1.29
Guidance for the preparation of neurological management guidelines by EFNS scientific task forces--revised recommendations 2004. Eur J Neurol (2004) 1.28
Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy. Brain (1985) 1.26
How affected is oxygen metabolism in DWI lesions?: A combined acute stroke PET-MR study. Neurology (2006) 1.25
Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry. Neuropsychologia (2008) 1.25
Sperm morphological defects related to environment, lifestyle and medical history of 1001 male partners of pregnant women from four European cities. Hum Reprod (2001) 1.20
[Letter: Toxic polyneuritis in a plastic worker. Possible role of methyl-ethyl-ketone]. Nouv Presse Med (1975) 1.20
Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment. Eur J Nucl Med Mol Imaging (2012) 1.19
Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease. Neurosci Lett (1999) 1.16
Semen quality and male reproductive health: the controversy about human sperm concentration decline. APMIS (2001) 1.15
Relations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer's disease: a PET/MRI correlative study. J Neurol Neurosurg Psychiatry (2001) 1.14
Early spontaneous hyperperfusion after stroke. A marker of favourable tissue outcome? Brain (1996) 1.11
Effects of healthy aging on the regional cerebral metabolic rate of glucose assessed with statistical parametric mapping. Neuroimage (1998) 1.10
Call-Fleming syndrome associated with subarachnoid haemorrhage: three new cases. J Neurol Neurosurg Psychiatry (2007) 1.09
Intra- and inter-individual variability in human sperm concentration, motility and vitality assessment during a workshop involving ten laboratories. Hum Reprod (2000) 1.09
Healthy aging, memory subsystems and regional cerebral oxygen consumption. Neuropsychologia (1995) 1.05
Sirolimus may reduce fertility in male renal transplant recipients. Am J Transplant (2008) 1.04
Progress in imaging stroke: emerging clinical applications. Br Med Bull (2003) 1.00
Probabilistic tractography of the optic radiations--an automated method and anatomical validation. Neuroimage (2009) 0.96
Regional differences in waiting time to pregnancy among fertile couples from four European cities. Hum Reprod (2001) 0.95
Does perfusion computed tomography facilitate clinical decision making for thrombolysis in unselected acute patients with suspected ischaemic stroke? Cerebrovasc Dis (2011) 0.95
Voxel-based mapping of irreversible ischaemic damage with PET in acute stroke. Brain (1999) 0.94
Second to fourth digit ratios, male genital development and reproductive health: a clinical study among fertile men and testis cancer patients. Int J Androl (2010) 0.94
Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery. Br J Pharmacol (2007) 0.94
The metabolic substrates of bradykinesia and tremor in uncomplicated Parkinson's disease. Neuroimage (2002) 0.93
The relationship between motor deficit and primary motor cortex hemispheric activation balance after stroke: longitudinal fMRI study. J Neurol Neurosurg Psychiatry (2010) 0.93
Macrostructural abnormalities in Korsakoff syndrome compared with uncomplicated alcoholism. Neurology (2012) 0.93
Thrombolytic therapy for acute stroke in the United Kingdom: experience from the safe implementation of thrombolysis in stroke (SITS) register. QJM (2008) 0.92
Atrophy of the corpus callosum correlates with white matter lesions in patients with cerebral ischaemia. Neuroradiology (2000) 0.92
Delayed intrahemispheric remote hypometabolism. Correlations with early recovery after stroke. Cerebrovasc Dis (2000) 0.91
Do changes in oxygen metabolism in the unaffected cerebral hemisphere underlie early neurological recovery after stroke? A positron emission tomography study. Stroke (1996) 0.91
Perfusion CT helps decision making for thrombolysis when there is no clear time of onset. J Neurol Neurosurg Psychiatry (2006) 0.91
Mapping the visual recognition memory network with PET in the behaving baboon. J Cereb Blood Flow Metab (2000) 0.91
Successful childbirth after intracytoplasmic morphologically selected sperm injection without assisted oocyte activation in a patient with globozoospermia. Hum Reprod (2011) 0.91
Right frontal cortex hypometabolism in transient global amnesia. A PET study. Brain (1994) 0.90
The nature of semantic memory deficits in Alzheimer's disease: new insights from hyperpriming effects. Brain (2001) 0.89
Transient global amnesia: implicit/explicit memory dissociation and PET assessment of brain perfusion and oxygen metabolism in the acute stage. J Neurol Neurosurg Psychiatry (1997) 0.89
[Familial myopathy with "cytoplasmic body" (or "spheroid") type inclusions, disclosed by respiratory insufficiency]. Rev Neurol (Paris) (1989) 0.89
Musical and verbal semantic memory: two distinct neural networks? Neuroimage (2009) 0.89